[go: up one dir, main page]

SE8206546L - Bensoesyraderivat - Google Patents

Bensoesyraderivat

Info

Publication number
SE8206546L
SE8206546L SE8206546A SE8206546A SE8206546L SE 8206546 L SE8206546 L SE 8206546L SE 8206546 A SE8206546 A SE 8206546A SE 8206546 A SE8206546 A SE 8206546A SE 8206546 L SE8206546 L SE 8206546L
Authority
SE
Sweden
Prior art keywords
alkyl
substd
opt
alkenyl
forms
Prior art date
Application number
SE8206546A
Other languages
English (en)
Other versions
SE8206546D0 (sv
SE453390B (sv
Inventor
M Thominet
G Bulteau
J Acher
C Collignon
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7623835A external-priority patent/FR2360305A1/fr
Application filed by Ile De France filed Critical Ile De France
Publication of SE8206546D0 publication Critical patent/SE8206546D0/sv
Publication of SE8206546L publication Critical patent/SE8206546L/sv
Publication of SE453390B publication Critical patent/SE453390B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (3)

Patentkrav 1. Substituerade 2,3-alkylen-bis(oxi)bensoesyror for anvandning corn mellanfbreningar till framstallning'av terapeutiskt vardefulla, substituerade 2,3-alkylen-bis-(oxi)-bensamider, k annetecknade av den allmanna formeln: COOS (V) ' X van i A betecknar en alkylenkedja med 1-3 kolatomer, framst di. metylen, etylen eller propylen, X betecknar vate, halogen, hydroxi, alkoxi med 1-4 kolatomer, frAmst dametoxi, etoxi, propoxi, isoproPoxi, butoxi, isobu- toxi'eller t-butoxi, alkyl med 1-4 kolatomer, framstmetyl, etyl, propyl, isopropyl, butyl, isobutyl eller t-butyl, nitro eller acetamino, Y betecknarhalogen, 111110,4 amino eller acetamino, eller Y betecknarsulfonyl mekolatomer, framst ad metylwilfonyl, etylsulfonyl, propylsulfonyl, isopropylsulfonyl, butylsulfonyl, isobutylsulfonyl eller t-butylsulfonyl, eller sulfamoyl, C1-C4-alkylsulfamoyl, Ci-C4-dialkylsulfamoy1, adamantylsulfamoyl eller cykloalkylsulfamoyl eller ar bunden till X under bildning av en azimidogrupp, och betecknar vate, halogen, nitro eller.acetamino, eller ar bUnden till Y till alt bilda en azinidogrupp, med de villkoren, alt
1. nal, A betecknar metylen eller etylen och Z betecknar vate. X och Y joke samtidigt betecknar vale,
2. nal. X och 2 betecknar Irate och A betecknar metylen eller etylen, Y Sr skild frAn en bromatom,
3. nar X och Z betecknar vateatomer och A betecknar en metylengrUpp, Y joke betecknar nitro, acetamino eller amino, - nar Y och Z betecknar vateatomer och A betecknar en metylengrupp, X joke betecknar en metoxigrupp, saint - nar A betecknar en metylengrupp och Z betecknar X och Y joke-idigt betec'metoxi.
SE8206546A 1976-08-04 1982-11-17 Substituerade 2,3-alkylen-bis-(oxi)-bensoesyror for anvendning som mellanforeningar till framstellning av terapeutiskt verdefulla, substituerade 2,3-alkylen-bis-(oxi)-bensamider SE453390B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7623835A FR2360305A1 (fr) 1976-08-04 1976-08-04 Nouveaux 2,3-alkylene bis (oxy)benzamides substitues, leurs derives et leurs procedes de preparation

Publications (3)

Publication Number Publication Date
SE8206546D0 SE8206546D0 (sv) 1982-11-17
SE8206546L true SE8206546L (sv) 1982-11-17
SE453390B SE453390B (sv) 1988-02-01

Family

ID=9176558

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7708849A SE440776B (sv) 1976-08-04 1977-08-03 Sett att framstella substituerade 2,3-alkylen-bis(oxo)bensamider
SE8206546A SE453390B (sv) 1976-08-04 1982-11-17 Substituerade 2,3-alkylen-bis-(oxi)-bensoesyror for anvendning som mellanforeningar till framstellning av terapeutiskt verdefulla, substituerade 2,3-alkylen-bis-(oxi)-bensamider

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7708849A SE440776B (sv) 1976-08-04 1977-08-03 Sett att framstella substituerade 2,3-alkylen-bis(oxo)bensamider

Country Status (37)

Country Link
JP (1) JPS57167914A (sv)
AR (1) AR219709A1 (sv)
AT (1) AT358034B (sv)
AU (1) AU516033B2 (sv)
BE (1) BE857350A (sv)
BG (1) BG36496A3 (sv)
CA (1) CA1114371A (sv)
CH (1) CH629198A5 (sv)
CS (1) CS216246B2 (sv)
DD (1) DD133237A5 (sv)
DE (1) DE2760414C2 (sv)
DK (1) DK152366C (sv)
EG (1) EG12716A (sv)
ES (1) ES461175A1 (sv)
FI (1) FI63938C (sv)
GR (1) GR61351B (sv)
HK (2) HK40382A (sv)
HU (1) HU179064B (sv)
IE (2) IE45646B1 (sv)
IL (2) IL52644A0 (sv)
IN (1) IN145473B (sv)
LU (1) LU77897A1 (sv)
MC (1) MC1154A1 (sv)
MW (1) MW2077A1 (sv)
NL (1) NL172063C (sv)
NO (1) NO152133C (sv)
NZ (1) NZ184816A (sv)
OA (1) OA05728A (sv)
PH (3) PH22114A (sv)
PL (1) PL111071B1 (sv)
PT (1) PT66865B (sv)
RO (1) RO72963A (sv)
SE (2) SE440776B (sv)
SU (1) SU716523A3 (sv)
YU (1) YU40005B (sv)
ZA (1) ZA774701B (sv)
ZM (1) ZM6077A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027098D0 (en) * 1990-12-13 1991-02-06 Beecham Group Plc Pharmaceuticals
US10083697B2 (en) 2015-05-27 2018-09-25 Google Llc Local persisting of data for selectively offline capable voice action in a voice-enabled electronic device
JP6452575B2 (ja) * 2015-08-19 2019-01-16 株式会社トクヤマ ミルタザピンの製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1473829A (fr) * 1964-06-09 1967-03-24 Ile De France Nu-(tertiaire-aminoalkyl)-méthylène dioxybenzamides et leur préparation

Also Published As

Publication number Publication date
SU716523A3 (ru) 1980-02-15
NZ184816A (en) 1980-11-14
NO772739L (no) 1978-02-07
BE857350A (fr) 1978-02-01
RO72963A (ro) 1981-11-24
DD133237A5 (de) 1978-12-20
ATA569677A (de) 1980-01-15
AT358034B (de) 1980-08-11
IE45646L (en) 1978-02-04
MC1154A1 (fr) 1978-04-17
IL52644A0 (en) 1977-10-31
DK152366B (da) 1988-02-22
NL172063B (nl) 1983-02-01
AU516033B2 (en) 1981-05-14
CH629198A5 (fr) 1982-04-15
ZM6077A1 (en) 1979-05-21
PT66865B (fr) 1978-12-29
SE8206546D0 (sv) 1982-11-17
FI63938B (fi) 1983-05-31
HU179064B (en) 1982-08-28
PH17710A (en) 1984-11-19
NL172063C (nl) 1983-07-01
SE440776B (sv) 1985-08-19
IE45646B1 (en) 1982-10-20
IL66138A0 (en) 1982-09-30
EG12716A (en) 1979-09-30
ES461175A1 (es) 1978-12-01
DK152366C (da) 1988-07-25
PH22114A (en) 1988-06-01
YU188277A (en) 1983-01-21
AR219709A1 (es) 1980-09-15
JPS6259090B2 (sv) 1987-12-09
SE453390B (sv) 1988-02-01
FI63938C (fi) 1983-09-12
JPS57167914A (en) 1982-10-16
OA05728A (fr) 1981-05-31
PH18629A (en) 1985-08-23
PL111071B1 (en) 1980-08-30
PL200066A1 (pl) 1978-09-11
AU2750777A (en) 1979-02-08
SE7708849L (sv) 1978-02-05
PT66865A (fr) 1977-08-01
ZA774701B (en) 1979-01-31
FI772362A7 (sv) 1978-02-05
CS216246B2 (en) 1982-10-29
LU77897A1 (sv) 1978-02-09
NL7708616A (nl) 1978-02-07
MW2077A1 (en) 1978-12-13
IE45647B1 (en) 1982-10-20
BG36496A3 (bg) 1984-11-15
NO152133C (no) 1985-08-07
HK40382A (en) 1982-09-24
DK346977A (da) 1978-02-05
DE2760414C2 (sv) 1990-05-17
SE437027B (sv) 1985-02-04
NO152133B (no) 1985-04-29
CA1114371A (en) 1981-12-15
IE802409L (en) 1978-02-04
IN145473B (sv) 1978-10-21
GR61351B (en) 1978-10-26
HK40482A (en) 1982-09-24
YU40005B (en) 1985-06-30

Similar Documents

Publication Publication Date Title
Lesher et al. A new method for the preparation of 3-substituted-2-oxazolidones
SE9302080D0 (sv) New compounds
ES8101072A1 (es) Un procedimiento para la preparacion de nuevas benzamidas sustituidas
EP0127902A2 (en) Aminomethyl oxooxazolidinyl benzene derivatives useful as antibacterial agents
ATE108791T1 (de) Neue 4-oxobenzotriazine und 4-oxochinazoline.
KR900009660A (ko) 신규 화합물들
CA2010639A1 (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-thiones
PE13799A1 (es) Dihidropironas con actividad antiviral
GB1410511A (en) Thiazole cardiovascular agnets
SE8206546L (sv) Bensoesyraderivat
BG51155A3 (bg) Метод за получаване на производни на нафталина
EP0014470A3 (en) Benzazepine derivatives, process and intermediates for their preparation, their use and pharmaceutical compositions containing them
ES8303415A1 (es) Un procedimiento para la preparacion de nuevos derivados de 3-triazolo (4,5-6) (1,5) benzodiazepina.
FR2360305B1 (sv)
IE801386L (en) Benzoxepines.
SE8004129L (sv) Nya tetrahydropyridin-4-yl-indolderivat samt salter derav, framstellning och anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar
JPS5328181A (en) Production of nove substituted 2*33alkylenebis *oxy* benzoic acid
GB1428883A (en) 1,3-benzoxazine and phenyl-alkylamine derivatives
KR890009919A (ko) 4- 헤테로아릴-1,3- 벤조디아제핀 및 2-치환된-α-(헤테로아릴) 벤젠에탄아민, 이의 제조방법 및 약제로서의 이의 용도
RU94031211A (ru) Производные изатина, способ их получения и фармацевтическая композиция на их основе

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8206546-7

Effective date: 19930307

Format of ref document f/p: F